As coronavirus infections increase all over the United States, health authorities caution that a rising number of fully inoculated people are being admitted to hospitals or going to the emergency room. The concern regarding declining immunity against severe COVID infection comes as the U.S. Food and Drug Administration is anticipated to approve a vaccine booster dose produced by Pfizer and its German partner BioNTech SE for all adults ages 18 and up.

In an interview on Tuesday, the director of the National Institute of Allergy and Infectious Diseases (NIAID), Dr. Anthony Fauci, said that they’re likely to see an increase in COVID-related hospitalizations among vaccinated, but not boosted people. It is a large proportion, but not the majority by any means.

On Wednesday, in a White House COVID-19 Response briefing, Dr. Fauci stressed the importance of jabs and highlighted their effectiveness.

Dr. Rochelle Walensky, the U.S. CDC director, reported a waning in jab effectiveness among the elderly and inhabitants of long-term care facilities, several of whom were the first to become vaccine-eligible and to be immunized recent winter.

Walensky said they’ve 62M vaccine-eligible in America who have still not received their shots, adding the data that she shows Americans don’t lie. Jabs protect people, their families, their community. And importantly, it isn’t too late, as Miss Walensky has said, get immunized now.

How Many Americans Have Received Booster Doses?

At the same panel, the US CDC director gave similar statements, explaining that the agency is seeing a rise in emergency room visits among adults 65 and up, which are now again higher than for youngsters. Moreover, Rochelle Walensky pointed to new data on long-term care centers from the CDC’s National Healthcare Safety Network (NHSN) comparing COVID infection rates between vaccinated and vaccinate plus boosted people.

She also said that the coronavirus disease rate is noticeably lower for those who got their booster doses, demonstrating their additional shots are working well.

Walensky and Fauci stressed that most hospital admissions and fatalities are still among uninoculated people in America. Walensky added that studies found that people who haven’t got their doses continue to be more likely to get COVID, be more likely to be hospitalized, and have serious complications from COVID.

According to the CDC, the current weekly rate of hospitalizations is nearly 5300 daily. And almost 1 thousand in America are losing their lives from the fatal disease every day.

Still, it isn’t evident how many breakthrough hospital admissions there are. Though the US CDC has been tracking the rate of hospital admissions among fully inoculated people, its database shows data only through 28th August. However, according to the new data from the Centers for Disease Control and Prevention, an unimmunized person is at an elevenfold higher risk of death from COVID-19 than an inoculated one.

Fortunately, according to the CDC, nearly 31M Americans have received Moderna, Pfizer, or Janssen/Johnson & Johnson & Johnson vaccine boosters.

America Agreed with Pfizer Inc. to Buy Ten Million Treatment Courses of Its COVID-19 Pill

On Thursday, Joe Biden, the President of the United States, proclaimed that America has agreed to purchase 10M treatment courses of Pfizer Inc.’s new, but yet to be approved, COVID antiviral pill, Paxlovid, starting later this year and finalizing neat year. In a statement posted on the White House website, the US leader said that his government is proceeding to make sure these treatments would be easily accessible and free after approval from US FDA and US CDC.

In the news posted to Pfizer’s website on Thursday, Pfizer said the American government would pay around 5.29 Bn dollars for Paxlovid pending approval.

Read Also: Pfizer Seeks U.S. Approval of its COVID-19 antiviral pill, Paxlovid